
Cedars-Sinai Accelerator
Description
Cedars-Sinai Accelerator, based in Los Angeles, California, operates as a highly specialized accelerator program dedicated to fostering innovation in healthcare technology. Launched in collaboration with Techstars, the program leverages the vast resources and clinical expertise of Cedars-Sinai Medical Center, one of the nation's leading academic medical centers. This unique integration allows participating startups unparalleled access to clinicians, executives, and real-world data, enabling them to validate and pilot their solutions within a live healthcare environment. The accelerator primarily targets early-stage companies developing solutions in digital health, medical devices, diagnostics, and health information technology, aiming to address critical challenges in patient care and operational efficiency.
The accelerator runs a rigorous, three-month program designed to rapidly advance the development and market readiness of selected startups. Each company accepted into the program receives a significant initial investment of $100,000 via a convertible note, providing crucial early-stage capital. Beyond funding, the program offers intensive mentorship from industry experts, access to Cedars-Sinai's extensive network, and opportunities for product testing and validation within a leading hospital system. This hands-on approach is instrumental in helping startups refine their offerings and navigate the complex healthcare landscape.
Cedars-Sinai Accelerator is known for its selective process, typically accepting around 10 companies for each cohort from a large pool of global applicants. The program culminates in a Demo Day, where participating companies present their progress and solutions to a diverse audience of investors, industry leaders, and potential partners. By bridging the gap between innovative technology and clinical application, the accelerator plays a vital role in bringing disruptive healthcare solutions to market, ultimately aiming to improve patient outcomes and transform the delivery of care.
Investor Profile
Cedars-Sinai Accelerator has backed more than 97 startups, with 11 new investments in the last 12 months alone. The firm has led 41 rounds, about 42% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Pre Seed, Convertible Note rounds (top funding stages).
- Majority of deals are located in United States, Singapore, United Kingdom.
- Strong thematic focus on Health Care, Medical, Artificial Intelligence (AI).
- Led 11 rounds in the past year.
- Typical check size: $100K.
Stage Focus
- Seed (41%)
- Pre Seed (14%)
- Convertible Note (11%)
- Grant (10%)
- Non Equity Assistance (9%)
- Series Unknown (8%)
- Series A (4%)
- Series B (1%)
Country Focus
- United States (76%)
- Singapore (11%)
- United Kingdom (8%)
- Canada (2%)
- Sweden (1%)
- The Netherlands (1%)
Industry Focus
- Health Care
- Medical
- Artificial Intelligence (Ai)
- Software
- Information Technology
- Medical Device
- Machine Learning
- Biotechnology
- Hospital
- Wellness
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.